Ingmar Mederacke
- Epidemiology top 0.5%
- Hepatology top 0.2%
- Molecular Biology top 10%
- Surgery top 5%
- Immunology top 5%
- Co-authors
- Robert F. SchwabeDianne H. DapitoJean‐Philippe PradèreXueru MuChristine HsuJuliane S. TroegerRichard A. FriedmanGeum‐Youn Gwak
- Topics
- Liver Disease Diagnosis and Treatment (30 papers)Hepatitis C virus research (17 papers)Hepatitis B Virus Studies (15 papers)
- Cited by
- HepatologyEpidemiologyImmunology
- Partner nations
- GermanyUnited StatesTürkiye
In The Last Decade
Ingmar Mederacke
43 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Epidemiology 2.7k
- Hepatology 2.6k
- Molecular Biology 1.2k
- Surgery 776
- Immunology 564
Countries citing papers authored by Ingmar Mederacke
This map shows the geographic impact of Ingmar Mederacke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Mederacke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Mederacke more than expected).
Fields of papers citing papers by Ingmar Mederacke
This network shows the impact of papers produced by Ingmar Mederacke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Mederacke. The network helps show where Ingmar Mederacke may publish in the future.
Co-authorship network of co-authors of Ingmar Mederacke
This figure shows the co-authorship network connecting the top 25 collaborators of Ingmar Mederacke. A scholar is included among the top collaborators of Ingmar Mederacke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingmar Mederacke. Ingmar Mederacke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 13 | |
| 4 | 41 | |
| 5 | 32 | |
| 6 | 20 | |
| 7 | High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse liversbreakdown → | 407 |
| 8 | 63 | |
| 9 | 45 | |
| 10 | Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiologybreakdown → | 1035 |
| 11 | 12 | |
| 12 | Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Micebreakdown → | 392 |
| 13 | 5 | |
| 14 | 72 | |
| 15 | 29 | |
| 16 | 52 | |
| 17 | 32 | |
| 18 | Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection. | 36 |
| 19 | 3 | |
| 20 | 66 |
About Ingmar Mederacke
Ingmar Mederacke is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 46 papers that have together received 4.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (30 papers), Hepatitis C virus research (17 papers) and Hepatitis B Virus Studies (15 papers). The work is most often cited by research in Hepatology (2.6k citations), Epidemiology (2.7k citations) and Immunology (564 citations). Ingmar Mederacke has collaborated with scholars based in Germany, United States and Türkiye. Frequent co-authors include Robert F. Schwabe, Dianne H. Dapito, Jean‐Philippe Pradère, Xueru Mu, Christine Hsu, Juliane S. Troeger, Richard A. Friedman, Geum‐Youn Gwak, Peter Huebener and Heiner Wedemeyer. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.